Literature DB >> 567443

Development of radioimmunoassay for thromboxane B2.

H H Tai, B Yuan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 567443     DOI: 10.1016/0003-2697(78)90683-8

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


× No keyword cloud information.
  6 in total

1.  Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo.

Authors:  G Ostermann; B Hofmann; H P Kertscher; U Till
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-12       Impact factor: 3.000

2.  Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid.

Authors:  M W Wilson; L T Lay; C K Chow; H H Tai; L W Robertson; H P Glauert
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

3.  Agonist-induced lipoxin A4 generation: detection by a novel lipoxin A4-ELISA.

Authors:  B D Levy; S Bertram; H H Tai; E Israel; A Fischer; J M Drazen; C N Serhan
Journal:  Lipids       Date:  1993-12       Impact factor: 1.880

4.  Production of platelet thromboxane A2 inactivates purified human platelet thromboxane synthase.

Authors:  E R Hall; W M Tuan; D L Venton
Journal:  Biochem J       Date:  1986-02-01       Impact factor: 3.857

5.  Dissociation of systemic and renal effects in endotoxemia. Prostaglandin inhibition uncovers an important role of renal nerves.

Authors:  W L Henrich; Y Hamasaki; S I Said; W B Campbell; R E Cronin
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

6.  Abnormal platelet response to thromboxane A2.

Authors:  K K Wu; G C Le Breton; H H Tai; Y C Chen
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.